BIOLASE INC's ticker is BIOL and the CUSIP is 090911207. A total of 1 filers reported holding BIOLASE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,069,000 | -9.4% | 3,025,769 | +0.0% | 0.00% | – |
| Q4 2021 | $1,180,000 | -38.7% | 3,024,689 | +0.4% | 0.00% | – |
| Q3 2021 | $1,926,000 | -8.4% | 3,013,306 | +0.1% | 0.00% | – |
| Q2 2021 | $2,102,000 | -30.4% | 3,010,754 | -16.0% | 0.00% | – |
| Q1 2021 | $3,020,000 | +2572.6% | 3,583,531 | +1225.7% | 0.00% | – |
| Q4 2020 | $113,000 | +52.7% | 270,318 | +0.1% | 0.00% | – |
| Q3 2020 | $74,000 | -40.8% | 270,063 | +0.0% | 0.00% | – |
| Q2 2020 | $125,000 | +7.8% | 270,060 | -12.3% | 0.00% | – |
| Q1 2020 | $116,000 | -29.3% | 307,919 | +3.5% | 0.00% | – |
| Q4 2019 | $164,000 | -41.2% | 297,545 | -0.1% | 0.00% | – |
| Q3 2019 | $279,000 | -36.6% | 297,704 | -0.4% | 0.00% | – |
| Q2 2019 | $440,000 | -36.0% | 298,875 | +3.4% | 0.00% | – |
| Q1 2019 | $688,000 | +139.7% | 289,177 | -0.3% | 0.00% | – |
| Q4 2018 | $287,000 | -52.1% | 290,084 | +0.3% | 0.00% | – |
| Q3 2018 | $599,000 | +72.1% | 289,182 | +0.4% | 0.00% | – |
| Q2 2018 | $348,000 | – | 288,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 3,134,100 | $2,004,000 | 1.24% |
| GSA CAPITAL PARTNERS LLP | 1,254,547 | $802,000 | 0.08% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,189 | $511,000 | 0.06% |
| DCM Advisors, LLC | 97,000 | $62,000 | 0.02% |
| Orion Capital Management LLC | 50,000 | $32,000 | 0.02% |
| Virtu Financial LLC | 208,765 | $133,000 | 0.01% |
| MONECO Advisors, LLC | 30,000 | $19,000 | 0.01% |
| CFO4Life Group, LLC | 33,200 | $21,000 | 0.01% |
| Zhang Financial LLC | 12,500 | $8,000 | 0.00% |
| Wellington Shields & Co., LLC | 10,000 | $6,000 | 0.00% |